Tkalčić et al., 2011 - Google Patents
Odor identification and cognitive abilities in Alzheimer's diseaseTkalčić et al., 2011
View PDF- Document ID
- 2156882556561108519
- Author
- Tkalčić M
- Spasić N
- Ivanković M
- Pokrajac-Bulian A
- Bosanac D
- Publication year
- Publication venue
- Translational Neuroscience
External Links
Snippet
Research results indicate systemic odor identification deficits in patients with Alzheimer's disease (AD). The aims of this study were: 1) to compare the ability to identify different odors and to compare cognitive status among patients with AD, patients with vascular dementia …
- 206010001897 Alzheimer's disease 0 title abstract description 113
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
- A61B5/4088—Diagnosing of monitoring cognitive diseases, e.g. Alzheimer, prion diseases or dementia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/16—Devices for psychotechnics; Testing reaction times; Devices for evaluating the psychological state
- A61B5/165—Evaluating the state of mind, e.g. depression, anxiety
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4005—Detecting, measuring or recording for evaluating the nervous system for evaluating the sensory system
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Stamps et al. | A brief olfactory test for Alzheimer's disease | |
Conti et al. | Odor identification deficit predicts clinical conversion from mild cognitive impairment to dementia due to Alzheimer's disease | |
Drew et al. | Executive dysfunction and cognitive impairment in a large community-based sample with Multiple Sclerosis from New Zealand: a descriptive study | |
Stern et al. | Diagnosis of dementia in a heterogeneous population: development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education | |
Leonhardt et al. | Awareness of olfactory dysfunction in Parkinson’s disease. | |
Caccappolo-Van Vliet et al. | The neuropsychological profiles of mild Alzheimer's disease and questionable dementia as compared to age-related cognitive decline | |
Hasemann et al. | Nurses' recognition of hospitalized older patients with delirium and cognitive impairment using the delirium observation screening scale: a prospective comparison study | |
Dolcos et al. | Mild cognitive impairment is associated with selected functional markers: integrating concurrent, longitudinal, and stability effects. | |
Lebkuecher et al. | The role of language ability in verbal fluency of individuals with multiple sclerosis | |
Lehrner et al. | Semantic memory and depressive symptoms in patients with subjective cognitive decline, mild cognitive impairment, and Alzheimer's disease | |
Andrés et al. | Quantifying memory deficits in amnestic mild cognitive impairment | |
Cha et al. | Associations between cognitive function, depression, and olfactory function in elderly people with dementia in Korea | |
Miebach et al. | Different cognitive complaint profiles in memory clinic and depressive patients | |
Tkalčić et al. | Odor identification and cognitive abilities in Alzheimer’s disease | |
Leyhe et al. | Clock test deficits are associated with semantic memory impairment in Alzheimer disease | |
Davis et al. | The detection of simulated malingering using a computerized priming test | |
Jacobs et al. | Characterization of depression in Alzheimer's disease by the CERAD Behavior Rating Scale for Dementia (BRSD) | |
Satler et al. | Cognitive anosognosia and behavioral changes in probable Alzheimer's disease patients | |
Trimarchi et al. | Signs and symptoms method in neuropsychology: A standardized observational examination of cognitive functions can be effective in detecting mild cognitive impairment. | |
La Rue et al. | Neuropsychological assessment | |
Piguet et al. | Boston naming test:: normative data for older Australians | |
Varela et al. | A systematic review of the utility of continuous performance tests among adults with ADHD | |
Morris | Neuropsychology of older adults | |
Selin et al. | Schizophrenia, conduct disorder and depressive disorder: neuropsychological, speech sample and EEG results | |
Hildebrandt | Neuropsychological tools for dementia: Differential diagnosis and treatment |